The Combination of a Novel GLUT1 Inhibitor and Cisplatin Synergistically Inhibits Breast Cancer Cell Growth By Enhancing the DNA Damaging Effect and Modulating the Akt/mTOR and MAPK Signaling Pathways

• Main Authors: Hao-Cheng Weng (Author), Chieh-Ju Sung (Author), Jui-Ling Hsu (Author), Wohn-Jenn Leu (Author), Jih-Hwa Guh (Author), Fan-Lu Kung (Author), Lih-Ching Hsu (Author)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2022-05-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Breast cancer is the most prevalent cancer and the second leading cause of cancer death in women. Cisplatin is a commonly used chemotherapeutic drug for breast cancer treatment. Owing to serious side effects, the combination of cisplatin with other drugs is an effective strategy to simultaneously re...